Report #2829462

Overview

Sex

Male

Age

Age unknown

State

AL

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

The patient took Vivotif capsules two days in a row instead of every other day.; Case reference number US-BN-2024-000052 is a spontaneous case report initially received from a pharmacist via Med Communication (reference number: USBAV24-0075) on 11-Jan-2024 and concerns a male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient took a dose of Vivotif (batch number: unknown) at an unknown dose, orally for typhoid prophylaxis. On an unspecified date, reported as two days in a row instead of every other day, the patient took another dose of Vivotif (batch number: unknown) at an unknown dose, orally (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A male patient of unspecified age took a dose of Vivotif for typhoid prophylaxis. Reportedly, on an unspecified date, reported as two days in a row instead of every other day, the patient took another dose of Vivotif, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unspecified age took a dose of Vivotif for typhoid prophylaxis. Reportedly, on an unspecified date, reported as two days in a row instead of every other day, the patient took another dose of Vivotif, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.

Medical history

Comments: None.